Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 6/2014

01-06-2014 | Research Article

Increased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis

Authors: Jihua Yang, Shunchang Jiao

Published in: Tumor Biology | Issue 6/2014

Login to get access

Abstract

The rs2736100 polymorphism in the telomerase reverse transcriptase (TERT) gene has been implicated in lung cancer risk in multiple populations, but the existing evidence lacks statistical power to draw a convincing conclusion. Therefore, the present study was devised to derive a more precise estimation of the association between rs2736100 and lung cancer risk. The PubMed, Embase, and Web of Science databases were comprehensively searched for papers concerning lung cancer risk in relation to rs2736100. Pooled odds ratios (ORs) and the 95 % confidence intervals (CIs) were appropriately calculated using the fixed or random effects model. Meta-analysis of 20 independent studies involving 39,715 cancer cases and 61,462 control subjects showed statistical evidence for an association between rs2736100 and increased risk of lung cancer. Subgroup analysis by ethnicity demonstrated a significant association among both Asian and Caucasian populations. We additionally found an increased risk of non-small cell lung cancer and lung adenocarcinoma strongly associated with rs2736100. These data provide further evidence supporting a role for genetic susceptibility of TERT rs2736100 in the development of lung cancer.
Literature
1.
Ferlay J et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.CrossRefPubMed
2.
Chen W, Zhang S, Zou X. Evaluation on the incidence, mortality and tendency of lung cancer in China. Thoracic Cancer. 2010;1:35–40.CrossRef
3.
Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol. 2000;18(11):2309–15.PubMed
4.
Kiyohara C et al. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer. 2002;37(3):241–56.CrossRefPubMed
5.
Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93(7):825–33.PubMedCentralCrossRefPubMed
6.
Hwang SJ et al. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet. 2003;113(3):238–43.CrossRefPubMed
7.
Fletcher O et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004;96(5):357–63.CrossRefPubMed
8.
9.
10.
11.
12.
Miki D et al. Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet. 2010;42(10):893–6.CrossRefPubMed
13.
Hu Z et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet. 2011;43(8):792–6.CrossRefPubMed
14.
Jin G et al. Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis. 2009;30(6):987–90.CrossRefPubMed
15.
Kohno T et al. Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma. J Thorac Oncol. 2011;6(4):813–7.CrossRefPubMed
16.
Wang Y et al. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis. 2010;31(2):234–8.CrossRefPubMed
17.
Shiraishi K et al. A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat Genet. 2012;44(8):900–3.CrossRefPubMed
18.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.CrossRefPubMed
19.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.PubMed
20.
21.
22.
Zhong R, et al. Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population. Mol Carcinog, 2013;52 Suppl 1:E118–26.
23.
24.
Zhao Z et al. Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population. Exp Lung Res. 2013;39(2):91–8.CrossRefPubMed
25.
Brenner DR et al. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet. 2013;132(5):579–89.PubMedCentralCrossRefPubMed
26.
Bae EY et al. Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology. 2012;17(4):699–706.CrossRefPubMed
27.
Chen XF et al. Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. Genet Mol Res. 2012;11(1):370–8.CrossRefPubMed
28.
Yoon KA et al. A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet. 2010;19(24):4948–54.CrossRefPubMed
29.
Myneni AA et al. Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer—a case-control study in a Chinese population. Lung Cancer. 2013;80(2):131–7.PubMedCentralCrossRefPubMed
30.
Ito H et al. Association between a genome-wide association study-identified locus and the risk of lung cancer in Japanese population. J Thorac Oncol. 2012;7(5):790–8.CrossRefPubMed
31.
Lan Q et al. Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS One. 2013;8(3):e59230.PubMedCentralCrossRefPubMed
32.
Lan Q et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet. 2012;44(12):1330–5.PubMedCentralCrossRefPubMed
33.
Truong T et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the international lung cancer consortium. J Natl Cancer Inst. 2010;102:959–71.PubMedCentralCrossRefPubMed
34.
35.
36.
Shen M et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer. 2011;73(2):133–7.PubMedCentralCrossRefPubMed
37.
Fu X et al. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection. Eur J Cancer. 2012;48(7):1014–22.PubMedCentralCrossRefPubMed
38.
39.
Shen J et al. Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival. Breast Cancer Res Treat. 2012;134(1):393–400.PubMedCentralCrossRefPubMed
40.
Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet. 1999;8(1):137–42.CrossRefPubMed
41.
Li C et al. Genetic variants in TERT-CLPTM1L genetic region associated with several types of cancer: a meta-analysis. Gene. 2013;526(2):390–9.CrossRefPubMed
42.
Wang HM, Zhang XY, Jin B. TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects. Genet Test Mol Biomarkers. 2013;17(12):937–41.PubMedCentralCrossRefPubMed
Metadata
Title
Increased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis
Authors
Jihua Yang
Shunchang Jiao
Publication date
01-06-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 6/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1765-8

Other articles of this Issue 6/2014

Tumor Biology 6/2014 Go to the issue

Research Article

Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer

Research Article

Upregulation of peripheral CD4+CXCR5+ T cells in osteosarcoma

Review

Genetic unraveling of colorectal cancer

Research Article

Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia

Research Article

Immunohistochemistry as a quick screening method for clinical detection of BRAF(V600E) mutation in melanoma patients

Research Article

MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits